Bioanalytical Developments for the Analysis of Antisense Oligonucleotides

Preclinical Strategies in Rodent Studies Using Volumetric Absorptive Microsampling (VAMS®)

Your CDMO Partner – From Formulation to Commercialization

 

In an industry where there is no shortage of drug development and manufacturing partners, you may ask:
WHY ALTASCIENCES?

Here are a few reasons:

  • We are highly skilled in handling complex formulations and highly potent compounds, and have tested or manufactured a wide variety of dosage forms.
  • We offer significant expertise in the production of liquid-filled capsules, using cutting-edge technology for an exceptionally high “Right First Time” rate in releasing quality batches.
  • We can resolve your solubility and bioavailability challenges with techniques such as nanomilling.
  • We offer fully integrated, end-to-end solutions, from discovery to preclinical to clinical proof of concept, and beyond. You will benefit from working with one partner to get your drug product to clinic, faster.

Watch to learn more on our expertise and how we can accelerate your drug development program.

Discover Altasciences - CDMO Services

Interested in speaking with one of our experts? Contact Us.

Quickly Advance Your Highly Potent API From Concept to Commercialization

 

Approximately 25 % of drugs in development worldwide are classified as highly potent active pharmaceutical ingredients (HPAPIs), and present substantial challenges and safety concerns to the pharmaceutical manufacturing industry.

At Altasciences, handling and developing HPAPIs into finished drug product, such as anti-cancer compounds and narcotics, is one of our core strengths. Our unique expertise, segregated grade C/D clean rooms, safety procedures, and advanced technology allow us to take your potent compounds from concept to commercial scale manufacturing, safely.

Learn more about our HPAPI handling and manufacturing capabilities here.

Need help with your HPAPI?

CHAT WITH AN EXPERT

Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.

.custom-column-left-text { float: left; width: 50%; padding-right: 10px; } .custom-column-right-text { float: right; width: 45%; text-align:center; } @media only screen and (max-width: 600px) { .custom-column-left-text, .custom-column-right-text, .custom-column-flc-ebook-text { float:none; width:80%; margin:0 auto; } }

Following decades of stagnation, the field of psychedelic research is being revitalized by the investigation of their potential benefit for mainstream psychiat

Subscribe to